Industry Experts – Market Research Reports

Industry Experts caters the market research needs of a broad range of industry verticals comprising Automotive, Healthcare, Food & Beverage, Telecom & Internet, Chemicals & Plastics, Biotechnology and Consumer Goods. The company also provides customized market research and industry analysis services for a wide range of industry sectors.

09 May

Emerging Markets to Lead Biosimilars Market Growth, Global Market to Reach $53 Billion by 2025 – Market Report (2018-2025) by Industry Experts, Inc.

Posted in Biotechnology, News on 09.05.19 by IE Admin

Industry Experts, Inc. unveiled the new 2019 version of its global market report on Biosimilars. The new version of the report entitled “Global Biosimilars Market – Products, Applications and Regulations” reveals that the global market for Biosimilar G-CSF is poised to post the fastest similar period CAGR of 33% and reach a projected US$7.3 billion by 2025.

Cost effectiveness, increasing geriatric population, rising incidences and prevalence of chronic ailments such as Cancer, Autoimmune Disorders and Diabetes and supportive government regulations and guidelines are some of the factors fueling the biosimilars market. Furthermore, the growth of the biosimilars market is retarded due to insufficient regulatory guideline, expensive research and development procedures and preference of patented products by the patients, etc. Patent expiry of most of the monoclonal antibody based biologics drives the biosimilar monoclonal antibody market. Oncology biosimilar market leads the biosimilars market and is primarily driven by the rising prevalence and incidence of cancer and patent expiry of the expensive biologics.

Monoclonal Antibodies constitute the single largest product type in the global Biosimilars market, demand for which is estimated at US$4.4 billion in 2018 and is projected to reach US$28.8 billion by 2025. The overall Biosimilars market in 2019 is expected to reach US$10.4 billion.

global biosimilars market

The report reviews, analyzes and projects the Biosimilars market for the period 2016-2025 in terms of USD. The market for Biosimilar product types analyzed in this study comprises Monoclonal Antibodies, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Insulin and Other product types (including Interferons, Follitropins, Recombinant Proteins etc.). The report also encompasses the market analysis for Therapeutic Areas consisting Oncology, Autoimmune Disorders, Blood Disorders, Growth Hormone Deficiency and Other therapeutic areas (including Chronic Diseases, Infectious Diseases, Cardiovascular Disorders etc.).

Global Biosimilars market is segmented into four major geographic regions, for the purpose of this study, namely Europe, North America, Asia-Pacific and Rest of World. These regional markets further analyzed for 14 independent countries across Europe – Germany, the United Kingdom, France, Spain and Italy; North America – the United States, Canada and Mexico; Asia-Pacific – China, India, Japan and South Korea; and Rest of World – Brazil and Israel.

This 364 page Biosimilars global market report includes 223 charts (includes a data table and graphical representation for each table), supported with a meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market by geographic region, product type and major therapeutic/application area. This report includes the brief business profiles of 26 key global players and 42 major players across North America – 10; Europe – 8; Asia-Pacific – 22; and Rest of World – 2. The report also provides the listing of the companies engaged in research & development, manufacturing and supply of Biosimilars. The global list of companies covers addresses, contact numbers and the website addresses of 151 companies.

California, USA based Industry Experts, Inc. is a multi-industry focused market research provider.

For more details, please visit http://industry-experts.com/verticals/biotechnology/global-biosimilars-market-products-applications-and-regulations

tags: , , , , , ,

No Comments »

26 Nov

Off-Patent Biologics to Boost the Growth of Biosimilars Global Market to Reach US$19.4bn by 2018

Posted in Biotechnology, News on 26.11.12 by IE Admin

Hyderabad – Industry Experts, a multi industry focused market research firm, has today announced a new market research report ‘Global Biosimilars Market – Products, Applications and Regulations’ to its Biotechnology catalogue.

Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the experience of marketing products for the last 5-10 years. On the other hand, several companies’ position is expected to be challenged over the next ten years, since the rapid growth forecast for the biosimilars market has attracted several new companies to enter this lucrative arena. Current leaders, in order to maintain market share, need to introduce new biosimilars over the next few years with a specific focus on the products in demand. Licensing deals are expected to expand the pipelines of established players, as well as new market entrants.

The global biosimilar market, estimated at US$2 billion in 2012 and expected to touch US$2.7 billion in 2013, is further projected to reach US$19.4 billion by 2018, exhibiting a CAGR of 36.6% over 2009-2018. This growth can be attributed to some of the top-selling biologics coming off-patent over the coming few years and biosimilar manufacturers are bound to make a beeline towards this lucrative opportunity.This report reviews, analyzes and projects the biosimilars market for global and regional markets including the United States, Europe, Asia-Pacific and Rest of World. The market numbers illustrated in this report only represent the market exclusively for the product segments and technologies enunciated above. The regional markets further analyzed for 8 more independent countries across Europe – France, Germany, Italy, Spain, the United Kingdom and Rest of Europe; Asia-Pacific – China, India, South Korea and Rest of Asia-Pacific.

The market for application areas of biosimilars analyzed in this study includes Blood Disorders, Chronic Diseases, Growth Hormone Deficiency, Oncology and Others. The report also encompasses the market analysis for product segments – Monoclonal Antibodies, Erythropoietin, Human Growth Hormone, Insulin, G-CSF, Interferons and Others.

This 354 page global market report includes 149 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market by geographic region, application area and product segment.The report covers the brief business profiles of 43 key global players and 54 major players across the United States – 13; Europe – 18; Asia-Pacific – 19 and Rest of World – 4. The report also provides the listing of the companies engaged in research and development, manufacturing, processing, supplies and distribution of biosimilars. Also enlisting the academic institutions and industry associations engaged in biosimilars, the global list covers the addresses, contact numbers and the website addresses of 168 companies.

For more details, please visit http://industry-experts.com/verticals/biotechnology/global-biosimilars-market-products-applications-and-regulations.html

tags: , ,

61 Comments »